Neuropace, Inc. NPCE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$21.57M+13.1% | -$21.47M+20.9% | -$23.99M+14.6% | -$25.94M+13.2% | -$24.81M+21.3% | ||
| $340K+14.5% | $329K+12.3% | $297K+4.2% | $297K+4.2% | $297K+4.2% | ||
| $10.74M+3.6% | $11.09M+7.8% | $11.09M+10.5% | $11.05M+12.0% | $10.37M+4.0% | ||
| -$9.93M+44.5% | -$11.51M+35.9% | -$16.31M+1.1% | -$16.09M+5.8% | -$17.9M-2.1% | ||
| $412K+72.4% | $332K+8.5% | $274K-8.4% | $344K+65.4% | $239K+64.8% | ||
| -$412K-106% | -$332K-104% | $1.73M-83.6% | $3.16M-76.3% | $6.56M-57.3% | ||
| —— | —— | —— | —— | $49.55M— | ||
| —— | —— | —— | —— | $25.36M+200% | ||
| —— | —— | —— | —— | —— | ||
| -$10.25M+43.5% | -$11.75M+35.7% | -$16.58M+1.2% | -$16.43M+4.9% | -$18.14M-2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neuropace, Inc. generate?
- Neuropace, Inc. (NPCE) generated -$9.9M in operating cash flow over the trailing twelve months.
- What is Neuropace, Inc.'s free cash flow?
- After $412.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$10.2M over the trailing twelve months, up 43.5% year over year.
- Where does Neuropace, Inc.'s cash flow data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
